These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 6056366)

  • 21. Massachusetts city attempts to import drugs form Canada.
    Caroll J
    Manag Care; 2003 Oct; 12(10):16-7. PubMed ID: 14598537
    [No Abstract]   [Full Text] [Related]  

  • 22. Regulating drugs for effectiveness and safety: a public health perspective.
    Zito JM; Socolar SJ; Eilers R; Crystal S; Lexchin J
    Med Care; 2007 Sep; 45(9):911. PubMed ID: 17712264
    [No Abstract]   [Full Text] [Related]  

  • 23. [The birth of new drugs].
    Petrányi G
    Orv Hetil; 1968 May; 109(21):Suppl:1-6. PubMed ID: 5720715
    [No Abstract]   [Full Text] [Related]  

  • 24. [Warranty regulation on drugs].
    Christoph KH
    Pharm Prax; 1967 Oct; 10():285-8. PubMed ID: 5633432
    [No Abstract]   [Full Text] [Related]  

  • 25. [Is the testing of drugs satisfactory?].
    Kohlhaas M
    Munch Med Wochenschr; 1970 Dec; 112(49):2224-6. PubMed ID: 5536811
    [No Abstract]   [Full Text] [Related]  

  • 26. [European legislation on biological similarity recommendations of the European Agency on Medications concerning drug quality].
    Prugnaud JL
    Nephrol Ther; 2009 Feb; 5 Spec No1():3-5. PubMed ID: 19233075
    [No Abstract]   [Full Text] [Related]  

  • 27. Systems validation for parenteral clinical drugs--application to R&D and QC laboratories.
    Tetzlaff RF
    J Parenter Sci Technol; 1983; 37(2):45-50. PubMed ID: 6345744
    [No Abstract]   [Full Text] [Related]  

  • 28. [Registration of animal drugs].
    Abrahams CG; Bax CD
    Tijdschr Diergeneeskd; 1991 Apr; 116(7):371-3. PubMed ID: 2031243
    [No Abstract]   [Full Text] [Related]  

  • 29. [Role of an association in promoting pharmaceutical quality assurance: transfer of know-how based on the buddy system].
    Ba A; Courcambeck A; Degui H
    Med Trop (Mars); 2006 Dec; 66(6):538-41. PubMed ID: 17286016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Drugs and their safety as secured by legal regulations from the aspect of the society at large].
    Kostka V; Solich J
    Cesk Zdrav; 1986 Sep; 34(8-9):360-3. PubMed ID: 3769040
    [No Abstract]   [Full Text] [Related]  

  • 31. [The new norms decreed by the legislative dirrective 91-93 CCE].
    Neri M; Palazzo S
    Boll Chim Farm; 1998 Feb; 137(2):31-4. PubMed ID: 9595832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. National drug policy in Nigeria. Interview by Daphne A. Fresle.
    Kuti OR
    J Public Health Policy; 1992; 13(3):367-73. PubMed ID: 1401053
    [No Abstract]   [Full Text] [Related]  

  • 33. The brand name versus generic controversy: Is there a segment of the pharmaceutical industry that produces drugs of higher quality?
    Marsh DA; Hoar ME
    Contemp Pharm Pract; 1982; 5(2):130-5. PubMed ID: 10317245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Harmful effects of drugs. Liability of the manufacturers against insurance claims for damages].
    Dahl B
    Ugeskr Laeger; 1984 Sep; 146(36):2726-8. PubMed ID: 6515894
    [No Abstract]   [Full Text] [Related]  

  • 35. ASHP technical assistance bulletin on quality assurance for pharmacy-prepared sterile products.
    Am J Hosp Pharm; 1993 Nov; 50(11):2386-98. PubMed ID: 8266973
    [No Abstract]   [Full Text] [Related]  

  • 36. [Counterfeiting of medicines, as a life threatening world tendency].
    Horgos J; Bartus G; Szente V; Hankó B; Zelkó R
    Acta Pharm Hung; 2009; 79(2):88-91. PubMed ID: 19634640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toward more effective drug regulation.
    Schmidt AM
    FDA Consum; 1975 Dec-1976 Jan; 9(10):27-9. PubMed ID: 10316532
    [No Abstract]   [Full Text] [Related]  

  • 38. [Private enterprise provides better and safer drugs].
    Monvall E
    Vardfacket; 1979 Mar; 3(6):17-8. PubMed ID: 258054
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical testing of drugs].
    Begemann H
    Med Klin; 1973 May; 68(18):569-71. PubMed ID: 4576603
    [No Abstract]   [Full Text] [Related]  

  • 40. Global perspective on specifications for biotechnology products--perspective from Japan.
    Hayakawa T
    Dev Biol Stand; 1997; 91():15-23. PubMed ID: 9413678
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.